Destruction before salvation

Mouse models of cancer are primarily soft tissue sarcomas and lymphomas, whereas 90% of human cancers are epithelial in origin. In the August 10 Nature, Artandi et al. suggest that the difference arises from higher levels of telomerase (the enzyme that adds a protective cap on the end of chromosomes) in mice (Nature 2000, 406:641-645). When the researchers combine a mouse telomerase knockout with a mutation in the tumor suppressor p53, non-reciprocal translocations appear, followed by epithelial

Written byWilliam Wells
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Mouse models of cancer are primarily soft tissue sarcomas and lymphomas, whereas 90% of human cancers are epithelial in origin. In the August 10 Nature, Artandi et al. suggest that the difference arises from higher levels of telomerase (the enzyme that adds a protective cap on the end of chromosomes) in mice (Nature 2000, 406:641-645). When the researchers combine a mouse telomerase knockout with a mutation in the tumor suppressor p53, non-reciprocal translocations appear, followed by epithelial cancers. Artandi et al. believe that low levels of telomerase lead to genome rearrangements that initiate tumorigenesis, before subsequent telomerase reactivation saves the cells from excessive rearrangements that would cause self-destruction.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform